Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-16-767889
Filing Date
2016-11-14
Accepted
2016-11-14 17:26:01
Documents
4
Period of Report
2016-08-31
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A d200649d8ka.htm 8-K/A 20950
2 EX-23.1 d200649dex231.htm EX-23.1 2952
3 EX-99.1 d200649dex991.htm EX-99.1 578361
4 EX-99.2 d200649dex992.htm EX-99.2 134725
  Complete submission text file 0001193125-16-767889.txt   738097
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K/A | Act: 34 | File No.: 000-26642 | Film No.: 161996020
SIC: 2835 In Vitro & In Vivo Diagnostic Substances